Quality testing of veterinary antimicrobial products used for livestock in Vietnam, 2018-2019.
Huong Quynh LuuThuy Nguyen Thi BichLong Ta HoangVera Irene EricksonPawin PadungtodPublished in: PloS one (2021)
Access to quality veterinary antimicrobial products contributes to efficient treatment of diseases in Vietnamese livestock and to reducing antimicrobial resistance (AMR). Poor quality antimicrobial drugs can lead to treatment failure, potentially influencing the inappropriate use of antimicrobials products, including increasing the dose, combining drugs, or changing to a broader spectrum antimicrobial. The objective of the study was to determine the actual concentration of antimicrobial active ingredient (AAI) in commercially available veterinary antimicrobial products as an indicator of their quality. A total of 144 veterinary antimicrobial products were purchased from randomly selected veterinary drug stores in 34 districts in eight provinces. For the qualitative analysis, we observed criteria linked to form, colour, and labelling information according to the Department of Animal Health regulations. For the quantitative analysis, high-performance liquid chromatography was used to determine the actual concentration of AAI in each sample. Of the 144 samples, 131 (91%) met the national standard of quality of being within ±10% of the labelled concentration. Ten antimicrobials (6.9%) contained less than half of the labelled content concentrations. Veterinary antimicrobial product quality control is an important part of addressing AMR. To support the national action plan to lower AMR, a veterinary drug quality control program should be implemented at all stages of the supply chain to assure high quality drugs and effective treatment of sick animals.
Keyphrases
- staphylococcus aureus
- quality control
- quality improvement
- antimicrobial resistance
- high performance liquid chromatography
- public health
- emergency department
- mental health
- mass spectrometry
- risk assessment
- systematic review
- high resolution
- tyrosine kinase
- tertiary care
- electronic health record
- solid phase extraction
- climate change
- adverse drug
- human health